Items where authors include "Morrison, M."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Morrison, M. orcid.org/0000-0001-6870-6673 and Bartlett, A. orcid.org/0000-0002-6927-0899 (2022) Making translational value: Identifying ‘good targets’ for clinical research on gene editing and induced pluripotent stem cell technologies. SSM - Qualitative Research in Health, 2. 100131. ISSN 2667-3215

Stephens, N., Morrison, M., Martin, P. et al. (1 more author) (2021) Spatiotemporal readiness is key to preparing regenerative medicine for the clinic. Regenerative Medicine, 16 (3). pp. 229-235. ISSN 1746-0751

Martin, P., Morrison, M., Turkmendag, I. et al. (4 more authors) (2020) Genome editing: the dynamics of continuity, convergence and change in the engineering of life. New Genetics and Society, 39 (2). pp. 219-242. ISSN 1463-6778

Morrison, M. and de Saille, S. orcid.org/0000-0002-8183-7771 (2019) CRISPR in context : towards a socially responsible debate on embryo editing. Palgrave Communications, 5. 110.